Results 151 to 160 of about 2,929 (206)

Additional considerations on vonoprazan triple therapy for <i>Helicobacter pylori</i> eradication: Implementation challenges and clinical perspectives. [PDF]

World J Gastroenterol
Sun CY, Chen MX.
europepmc   +1 more source

Endoscopic Examination and Long-Term Use of Proton Pump Inhibitors for Gastroesophageal Reflux Disease Treatment in Japan. [PDF]

Drug Healthc Patient Saf
Takami A, Terashima G, Shiotsuki Y, Yamashita K, Igarashi A.   +4 more
europepmc   +1 more source

Vonoprazan-based bismuth quadruple therapy for first-line Helicobacter pylori eradication: A real-world, retrospective study. [PDF]

Medicine (Baltimore)
Zhang JY, Wang YQ, Huang WF, Lei XY, Li J, Guo LY, Zhang XF.   +6 more
europepmc   +1 more source

Safety of Potassium-Competitive Acid Blockers Compared With Proton Pump Inhibitors in Patients With Gastroesophageal Reflux Disease and Peptic Ulcer Disease: A Systematic Review and Meta-Analysis. [PDF]

J Gastroenterol Hepatol
Jang Y, Park J, Kang D, Kim JH, Choi HS, Jeon HL, Lee H.   +6 more
europepmc   +1 more source

Comparison of Vonoprazan and Low-Dose Amoxicillin Dual Therapy with Bismuth-Containing Quadruple Therapy for Naïve <i>Helicobacter pylori</i> Eradication: A Single-Center, Open-Label, Randomized Control Trial. [PDF]

Antibiotics (Basel)
Fan X, Shi Y, Li Y, Lin X.
europepmc   +1 more source

Revisiting reflux therapy: vonoprazan as a potent PPI substitute. [PDF]

Ann Med Surg (Lond)
Khalid M, Kumari A, Kumari A, Amin MHJ.
europepmc   +1 more source

Clinical Outcomes of Tegoprazan Versus Proton Pump Inhibitors in Patients Receiving Antiplatelet Therapy After Percutaneous Coronary Intervention: A Retrospective, Observational Study. [PDF]

Korean J Helicobacter Up Gastrointest Res
Lee J, Park J, Park J, Park YE, Choi JH, Heo NY, Park SH, Kim TO.   +7 more
europepmc   +1 more source

Comparative efficacy and safety of vonoprazan versus esomeprazole-based high-dose dual therapies for first-line <i>Helicobacter pylori</i> eradication: a randomized controlled trial. [PDF]

Ther Adv Gastroenterol
Tai WC, Lu LS, Yang SC, Wang HM, Wu CK, Yao CC, Huang PY, Lee YC, Chuah SK, Liang CM.   +9 more
europepmc   +1 more source

Efficacy of Potassium-Competitive Acid Blockers in Functional Dyspepsia: A Systematic Review and Meta-Analysis. [PDF]

Gastroenterology Res
Nguyen HT, Vaghefi A, Khan T.
europepmc   +1 more source

Follow-up study of vonoprazan maintenance therapy for reflux esophagitis: A 96-week evaluation in patients with PPI-refractory disease. [PDF]

Biomed Rep
Mizuno H, Inagaki S, Yamada K, Kamiyamamoto S.   +3 more
europepmc   +1 more source